Sedative effect of Remifentanil in Senile Cataract Surgeries
Phase 2
- Conditions
- Cataract.Senile incipient cataract
- Registration Number
- IRCT201111268201N1
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
ASA physical status 2,3; Male or female age=65 ; No Allergic Reaction to Drug; No Drug abuse; No smoking. Exclusion criteria: hypoxia; nausea; vomiting.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method O2 saturation. Timepoint: During intravenous sedation. Method of measurement: Pulseoximeter.;Sedation score. Timepoint: Before regional block and every 10 minutes therafter until the end of operation. Method of measurement: MOAA/SS (Modified observer's assessment of alertness/sedation).;Blood pressure. Timepoint: During intravenous sedation. Method of measurement: By non-invasive blood pressure measuring.;Heart rate. Timepoint: During intravenus sedation. Method of measurement: ECG.
- Secondary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: During intravenous sedation. Method of measurement: Observe.;Bradycardia. Timepoint: during intravenous sedation. Method of measurement: Electrocardiogram (ECG).;Apnea. Timepoint: during intravenous sedation. Method of measurement: Respiratoty Rate.